Neuropace, Inc. Common Stock (NPCE) is a publicly traded Healthcare sector company. As of July 23, 2026, NPCE trades at $14.55 with a market cap of $527.09M and a P/E ratio of -22.72. NPCE moved +2.40% today. Year to date, NPCE is -5.57%; over the trailing twelve months it is +55.94%. Its 52-week range spans $7.56 to $19.60. Analyst consensus is strong buy with an average price target of $19.75. Rallies surfaces NPCE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NPCE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $14.55 |
| Market Cap | $527.09M |
| P/E Ratio | -22.72 |
| EPS | $-0.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.60 |
| 52-Week Low | $7.56 |
| Volume | 214.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $99.53M |
| Net Income | $-21.57M |
| Gross Margin | 78.29% |
4 analysts cover NPCE: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.75.